Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Ascites in Patients With Cirrhosis”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)UnknownNCT02818673
What this trial is testing

Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics

Who this might be right for
Refractory Ascites in Patients With Cirrhosis
Assistance Publique - Hôpitaux de Paris 30
Large-scale testing (Phase 3)Looking for participantsNCT06814626
What this trial is testing

Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome

Who this might be right for
Liver CirrhosisRefractory Ascites in Patients with CirrhosisSarcopenia in Liver Cirrhosis
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies 72
Post-approval studies (Phase 4)Study completedNCT01288794
What this trial is testing

Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis

Who this might be right for
Liver CirrhosisAscites
University of Bologna 431
Not applicableUnknownNCT03172273
What this trial is testing

Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites

Who this might be right for
Liver Cirrhoses
Air Force Military Medical University, China 180
Testing effectiveness (Phase 2)UnknownNCT01438970
What this trial is testing

Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function

Who this might be right for
Cirrhosis, LiverRefractory Ascites
Sequana Medical N.V. 12
Not applicableStudy completedNCT06196723
What this trial is testing

Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites

Who this might be right for
Refractory Ascites
Tang-Du Hospital 462
Large-scale testing (Phase 3)Study completedNCT02173288
What this trial is testing

Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites

Who this might be right for
CirrhosisRefractory/Recurrent Ascites
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Testing effectiveness (Phase 2)Study completedNCT03107091
What this trial is testing

Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites

Who this might be right for
CirrhosisAscites Hepatic
BioVie Inc. 6
Not applicableUnknownNCT04406298
What this trial is testing

Safety and Efficacy of Small Frequent Paracentesis Using an Indwelling CAtheter Compared With Repeated Large Volume Paracentesis in Cirrhotic Patients With REfractory Ascites

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 200
Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Not applicableUnknownNCT04816240
What this trial is testing

Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 200
Large-scale testing (Phase 3)UnknownNCT01558895
What this trial is testing

Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites

Who this might be right for
Liver CirrhosisRefractory Ascites
First People's Hospital of Foshan 40
Post-approval studies (Phase 4)Study completedNCT00741663
What this trial is testing

Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)

Who this might be right for
CirrhosisAscites
University of Padova 100
Not applicableActive Not RecruitingNCT04326946
What this trial is testing

International Alfapump Cohort Study

Who this might be right for
Liver CirrhosesMalignant Ascites
Sequana Medical N.V. 400
Large-scale testing (Phase 3)UnknownNCT01854125
What this trial is testing

Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites

Who this might be right for
Immune Function in BloodLiver Function in BloodVariation of Ascites+2 more
Nanjing PLA General Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04311489
What this trial is testing

Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.

Who this might be right for
Cirrhosis, LiverAscites Hepatic
University of Aarhus 17
Not applicableUnknownNCT04640116
What this trial is testing

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Who this might be right for
Liver DiseasesPortal HypertensionCirrhosis, Liver+2 more
Sun Yat-sen University 30
Large-scale testing (Phase 3)Study completedNCT00240045
What this trial is testing

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

Who this might be right for
Type 2 Hepatorenal SyndromeRefractory Ascites
University of Alberta 9
Large-scale testing (Phase 3)Study completedNCT00986817
What this trial is testing

Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin

Who this might be right for
Cirrhosis
Assistance Publique - Hôpitaux de Paris 82
Testing effectiveness (Phase 2)Ended earlyNCT04112199
What this trial is testing

Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites

Who this might be right for
AscitesDecompensated Cirrhosis
BioVie Inc. 15
Load More Results